Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

363
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
363
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

200
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

265
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
265
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

262
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
262
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

261
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
261

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative performance of methadone urine immunoassays based on real-world data reveals assay interference.

Journal of analytical toxicology·2026
Same author

Practical Considerations for Implementing Immunoassays for Urine Drug Testing in Clinical Laboratories.

Clinics in laboratory medicine·2025
Same author

Commentary on M Protein Interference in Renal Function Assays: A Quest for True Kidney Function.

The journal of applied laboratory medicine·2025
Same author

Plasma Is Denser than Cells and Gel Barrier. Is It Possible?

Clinical chemistry·2023
Same author

Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.

Scientific reports·2022
Same author

Missed critical value callbacks due to middleware flaw.

Clinical biochemistry·2021
Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026
Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026
Same journal

Biomarkers for assessing magnesium status.

Advances in clinical chemistry·2026
Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026
Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026
Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026
查看所有相关文章

相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K

结核病检测方面的进展

Jayson V Pagaduan1, Ghaith Altawallbeh1

  • 1Intermountain Central Laboratory Intermountain Medical Center, Murray, UT, United States.

Advances in clinical chemistry
|September 6, 2023
PubMed
概括
此摘要是机器生成的。

结核病 (TB) 仍然是全球主要的健康威胁,每年造成数百万人的死亡. 改善活跃和潜伏结核病的诊断工具对于实现终结结核病目标至关重要.

关键词:
干扰素玛释放测试试验潜在的结核病感染.结核病菌菌菌的结核病菌的结核病菌.核酸放大试验核酸放大试验结核素皮肤测试是一种结核素皮肤测试.结核病是一种疾病.基于结核抗原的皮肤试验.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K

相关实验视频

Last Updated: Jul 17, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K

科学领域:

  • 传染性疾病 传染性疾病
  • 微生物学 微生物学
  • 公共卫生 公共卫生

背景情况:

  • 在全球范围内,结核病 (TB) 是单一传染病原体导致死亡的首要原因,直到COVID-19大流行.
  • 2020年,有1000万人感染了结核病,150万人死亡.
  • 大约有20亿人潜伏感染了Mycobacterium结核病 (MTB),有5-10%的终身风险发展为活跃的结核病.

研究的目的:

  • 审查当前世界卫生组织 (WHO) 认可的结核病诊断测试.
  • 讨论活跃和潜伏结核病的诊断和查测试方面的进展.
  • 突出改善诊断对于实现2035年终结结核病目标的重要性.

主要方法:

  • 审查当前的世界卫生组织认可的结核病诊断技术.
  • 对结核病诊断的最新技术进步进行分析.
  • 讨论潜伏结核病感染 (LTBI) 的查策略.

主要成果:

  • 介绍了目前的诊断方法及其局限性.
  • 探索用于更准确和更容易获得的结核病诊断的新兴技术.
  • 强调了诊断和治疗潜伏性结核病的关键作用.

结论:

  • 准确和易于使用的诊断工具对于结核病控制至关重要.
  • 诊断技术的进步对于识别和治疗潜伏感染的个体至关重要.
  • 实现终结结核病的目标需要对活跃结核病和潜伏结核病的诊断能力进行重大改进.